Position in ONC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,646,395
+$3,177,981 QoQ
Shares Held
19,814
+138.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 282 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $570,630,052 across 169 Biotechnology names. ONC ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,085 | $81,009,212 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
273,506 | $65,906,740 | |
| 3 | TECH |
BIO-TECHNE Corp
|
502,361 | $35,491,804 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
47,009 | $29,311,991 | |
| 5 | RPRX |
Royalty Pharma plc
|
470,482 | $26,379,925 | |
| 6 | INCY |
Incyte Corp
|
214,446 | $24,309,598 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
546,694 | $19,347,500 | |
| 8 | MRNA |
Moderna, Inc.
|
219,606 | $15,379,008 |
All Filings in ONC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,646,395 | 19,814 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,468,414 | 8,312 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,032,488 | 6,690 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,903,831 | 5,588 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $898,321 | 3,711 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $698,932 | 2,568 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $248,804 | 1,347 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $295,006 | 1,314 | Shares | Sole | 2024-11-14 | |
| 2022-12-31 | $219,500 | 998 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||